Face-Splitting test shows gel may calm rosacea redness
NCT ID NCT07431476
Summary
This study tested whether a prescription gel called 0.33% brimonidine can reduce persistent facial redness in people with rosacea. Researchers applied the gel to one side of participants' faces and a placebo gel to the other side to compare immediate effects, then had participants use the gel daily for one month. They measured redness using special cameras and skin measurement devices to see both short-term and longer-term results.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ROSACEA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Istanbul Training and Research Hospital, Department of Dermatology
Istanbul, 34098, Turkey (Türkiye)
Conditions
Explore the condition pages connected to this study.